Yes. QuickRx Specialty Pharmacy offers completely free enrollment support for Sprycel copay assistance programs. We don’t charge application fees or service charges—our mission is to help you access affordable treatment.

Our free Sprycel copay services include:

• Complete application assistance for copay cards and financial aid programs
• Insurance benefit verification and coverage analysis
• Prior authorization coordination when required
• Continuous benefit monitoring to maintain your savings
• Nationwide home delivery coordination

Eligibility depends on your insurance type, medical diagnosis, and financial circumstances:

For commercially insured patients: Manufacturer copay cards are available for patients with private insurance. Most commercial plans qualify.

For Medicare patients: Patient assistance programs and foundation grants may be available based on income eligibility.

For Medicaid and uninsured patients: Patient assistance programs may provide Sprycel at no cost based on income qualification.

Call QuickRx at (917) 830-2525 for a free eligibility assessment.

QuickRx Specialty Pharmacy helps you apply for Sprycel copay cards—we handle the paperwork so you don’t have to:

1. Contact QuickRx: Call (917) 830-2525 or complete the form on this page
2. Provide information: Share your prescription and insurance details
3. We apply for you: Our team submits your copay card application on your behalf
4. Start saving: Once approved, discounts are applied automatically at the pharmacy

Most patients receive approval within 24-48 hours.

Medicare patients cannot use manufacturer copay cards due to federal regulations. However, QuickRx helps Medicare patients access alternative assistance:

• Patient Assistance Programs (PAPs): Income-based programs that may provide Sprycel at no cost
• Foundation grants: Independent charitable foundations that help with medication costs
• Medicare Part D optimization: We help ensure you’re in the best plan for your medications

Contact QuickRx for help finding Medicare-compatible Sprycel assistance programs.

Savings vary based on your insurance coverage and the assistance programs you qualify for:

• Commercially insured patients: Eligible patients may pay $0 to $50 per month with manufacturer copay cards
• Patient assistance programs: Qualified patients may receive Sprycel at no cost
• Foundation grants: May cover remaining out-of-pocket costs after insurance

QuickRx provides personalized cost estimates based on your specific situation.

Sprycel (dasatinib) is an FDA-approved tyrosine kinase inhibitor used to treat certain types of blood cancers. It was first approved by the FDA on June 28, 2006 and is manufactured by Bristol-Myers Squibb. Generic dasatinib is also available.

How Sprycel works:

Dasatinib works by blocking BCR-ABL tyrosine kinase, an abnormal protein that causes cancer cells to grow and multiply. By inhibiting this protein, Sprycel helps stop the growth and spread of leukemia cells.

Sprycel also inhibits other kinases including SRC family kinases, c-KIT, and platelet-derived growth factor receptor (PDGFR).

For more information about tyrosine kinase inhibitors, visit the National Cancer Institute.

Sprycel is FDA-approved to treat:

Chronic Myeloid Leukemia (CML), Philadelphia chromosome-positive:

• Newly diagnosed adults in chronic phase
• Patients with resistance or intolerance to prior therapy including imatinib
• Pediatric patients with chronic phase CML

Acute Lymphoblastic Leukemia (ALL), Philadelphia chromosome-positive:

• Adults with resistance or intolerance to prior therapy
• Newly diagnosed pediatric patients in combination with chemotherapy

Learn more about CML treatment at the Leukemia & Lymphoma Society.

Standard dosing:

• Chronic phase CML: 100 mg once daily
• Accelerated or blast phase CML: 140 mg once daily
• Ph+ ALL: 140 mg once daily

Administration instructions:

• Sprycel can be taken with or without food
• Swallow tablets whole—do not crush, cut, or chew
• Take at approximately the same time each day
• If you miss a dose, take it as soon as you remember unless it’s almost time for your next dose
• Do not take two doses at the same time

Always follow your oncologist’s specific dosing instructions.

Common side effects (occurring in more than 10% of patients):

• Fluid retention and swelling
• Diarrhea
• Headache
• Skin rash
• Nausea and vomiting
• Fatigue
• Muscle and joint pain
• Shortness of breath
• Low blood cell counts (anemia, neutropenia, thrombocytopenia)
• Bleeding
• Infections
• Fever

Report any side effects to your healthcare provider. For complete safety information, see the Sprycel prescribing information.

Contact your healthcare provider immediately if you experience:

• Pleural effusion: Shortness of breath, chest pain, dry cough
• Bleeding: Unusual bruising, blood in urine or stool, coughing up blood
• Heart problems: Chest pain, irregular heartbeat, swelling in legs
• Pulmonary arterial hypertension: Shortness of breath, fatigue, fainting
• Severe skin reactions: Blistering, peeling skin, mouth sores
• Liver problems: Yellowing of skin or eyes, dark urine
• Signs of infection: Fever, chills, persistent cough

Your oncologist will monitor you regularly with blood tests and imaging to watch for these complications.

Sprycel can interact with many other medications. Tell your healthcare provider about all prescription and over-the-counter medications you take.

Important drug interactions:

• CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin): May increase dasatinib levels
• CYP3A4 inducers (rifampin, phenytoin, carbamazepine): May decrease dasatinib effectiveness
• Antacids and acid reducers: PPIs and H2 blockers can reduce dasatinib absorption—avoid within 2 hours of your dose
• Blood thinners and antiplatelet agents: Increased bleeding risk
• St. John’s Wort: Avoid—may reduce dasatinib effectiveness

Filling all prescriptions at the same pharmacy helps identify potential interactions.

No—avoid grapefruit and grapefruit juice while taking Sprycel.

Grapefruit can increase dasatinib blood levels and increase the risk of side effects. This interaction occurs because grapefruit inhibits the CYP3A4 enzyme that metabolizes dasatinib.

Other food considerations:

• Sprycel can be taken with or without food
• Avoid excessive alcohol consumption
• Discuss any dietary supplements with your healthcare provider

Pregnancy: Sprycel can harm an unborn baby and should not be taken during pregnancy. Patients who could become pregnant should use effective contraception during treatment and for 30 days after the last dose.

Breastfeeding: It is not known if dasatinib passes into breast milk. Breastfeeding is not recommended during Sprycel treatment and for 2 weeks after the last dose.

Fertility: Dasatinib may affect fertility in both males and females. Discuss fertility preservation options with your healthcare provider before starting treatment.

If you become pregnant while taking Sprycel, contact your healthcare provider immediately.

Sprycel (dasatinib) is available as oral tablets in the following strengths:

• 20 mg tablets
• 50 mg tablets
• 70 mg tablets
• 80 mg tablets
• 100 mg tablets
• 140 mg tablets

Generic dasatinib is also available in all the same strengths from multiple manufacturers.

QuickRx dispenses both brand Sprycel and generic dasatinib based on your prescription and insurance coverage.

Yes. Generic dasatinib is FDA-approved to be bioequivalent to brand Sprycel, meaning it contains the same active ingredient in the same strength and works the same way in the body.

Key points about generic dasatinib:

• Same active ingredient (dasatinib)
• Same dosage strengths available
• FDA-approved for the same indications
• Often more affordable than brand Sprycel
• May be covered differently by insurance

QuickRx can help you determine whether brand Sprycel or generic dasatinib is the most cost-effective option for your situation. Call (917) 830-2525 for assistance.

You can read the full Sprycel (Dasatinib) package insert on the Bristol-Myers Squibb Package Insert page by clicking here. 

Getting started with QuickRx Specialty Pharmacy is easy:

1. Contact us: Call (917) 830-2525 or toll-free (800) 496-6111, or complete the form on this page
2. Transfer your prescription: We’ll coordinate with your oncologist to transfer your Sprycel prescription
3. Copay assistance enrollment: Our team identifies and enrolls you in all eligible assistance programs
4. Home delivery: Receive your medication delivered directly to your door nationwide

QuickRx provides 24/7 pharmacist support, automatic refill reminders, and ongoing copay assistance monitoring to ensure you never experience gaps in your leukemia treatment.

The medical information on this page is based on peer-reviewed clinical literature and authoritative drug references:

• Sprycel (dasatinib) Prescribing Information – Bristol-Myers Squibb
• FDA Drug Approval Database – U.S. Food and Drug Administration
• Dasatinib Drug Information – National Cancer Institute
• Chronic Myeloid Leukemia – Leukemia & Lymphoma Society
• Lexicomp. Dasatinib: Drug information. UpToDate. Accessed December 2025.
• Cortes JE, et al. Final 5-year study results of DASISION. J Clin Oncol. 2016;34(20):2333-2340.

Medical Disclaimer: This page provides educational information about Sprycel (dasatinib) copay assistance programs and is not intended as medical advice. Program details, eligibility requirements, and savings amounts may change. All treatment decisions should be made in consultation with your qualified healthcare provider.

Page reviewed by: Julia Kravtsova, PharmD
Last Updated: December 2025

QuickRx Specialty Pharmacy is an independent pharmacy and is not affiliated with Bristol-Myers Squibb or the manufacturers of generic dasatinib products.